Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
Kontaktai Skambindami pasakykite, kad skelbim radote portale Nemokamiskelbimai.lt
Supports radiant, even-toned skin*
HUBERMAN: And it's one for which we are just now really starting to appreciate how many different peptides the human body and brain make
References: References:
01022-6/asset/419d8465-83ce-4d57-9972-6021e1483742/main.assets/gr2.jpg)
